All terms
Early Feasibility Study
FDA program enabling early human evaluation of novel devices with limited preclinical data and iterative design.
Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026
Definition
EFSs allow first-in-human use of a novel device based on less nonclinical evidence than a traditional IDE, with allowances for iterative device modifications during the study.What this means in practice
Strategically valuable for breakthrough cardiovascular, neuro, and surgical devices needing early clinical signal to inform design freeze.Primary references
3 sourcesLink health: 2 verified 1 bot-blocked· last checked 2026-05-09
FDA·2ISO·1
- 1
FDA EFS GuidanceBot-blockedFDAfda.gov
- 2
ISO 14155 Standard PageVerifiedISOiso.org
- 3
FDA - Clinical Trials and Human Subject ProtectionVerifiedFDAfda.gov
Inline markers like [1] jump to the matching reference above.